108 related articles for article (PubMed ID: 1394436)
1. Agonistic effects of tyrphostins on human peripheral mononuclear cells.
Lander HM; Levine DM; Novogrodsky A
Cell Immunol; 1992 Oct; 144(1):155-68. PubMed ID: 1394436
[TBL] [Abstract][Full Text] [Related]
2. Haemin enhancement of glucose transport in human lymphocytes: stimulation of protein tyrosine phosphatase and activation of p56lck tyrosine kinase.
Lander HM; Levine DM; Novogrodsky A
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):281-7. PubMed ID: 8471045
[TBL] [Abstract][Full Text] [Related]
3. Multiple effects of staurosporine, a kinase inhibitor, on thymocyte functions. Comparison with the effect of tyrosine kinase inhibitors.
Zilberman Y; Gutman Y
Biochem Pharmacol; 1992 Oct; 44(8):1563-8. PubMed ID: 1417980
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
Gillespie J; Dye JF; Schachter M; Guillou PJ
Br J Cancer; 1993 Dec; 68(6):1122-6. PubMed ID: 8260363
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Moloney murine leukemia virus replication by tyrphostins, tyrosine kinase inhibitors.
Esther A; Iftach S; Esther P
FEBS Lett; 1994 Mar; 341(1):99-103. PubMed ID: 8137930
[TBL] [Abstract][Full Text] [Related]
7. Late administration of a lipophilic tyrosine kinase inhibitor prevents lipopolysaccharide and Escherichia coli-induced lethal toxicity.
Vanichkin A; Patya M; Gazit A; Levitzki A; Novogrodsky A
J Infect Dis; 1996 Apr; 173(4):927-33. PubMed ID: 8603973
[TBL] [Abstract][Full Text] [Related]
8. The tryphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2.
Palumbo GA; Yarom N; Gazit A; Sandalon Z; Baniyash M; Kleinberger-Doron N; Levitzki A; Ben-Yehuda D
Cancer Res; 1997 Jun; 57(12):2434-9. PubMed ID: 9192822
[TBL] [Abstract][Full Text] [Related]
9. Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells.
Erlinge D; Heilig M; Edvinsson L
Br J Pharmacol; 1996 Jun; 118(4):1028-34. PubMed ID: 8799578
[TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated activation of human B lymphocytes in a nonphosphotyrosine-dependent manner.
Roifman CM; Wang G
J Immunol; 1992 Aug; 149(4):1179-84. PubMed ID: 1380035
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor.
Ohmichi M; Pang L; Ribon V; Gazit A; Levitzki A; Saltiel AR
Biochemistry; 1993 May; 32(17):4650-8. PubMed ID: 7683492
[TBL] [Abstract][Full Text] [Related]
12. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins.
Párrizas M; Gazit A; Levitzki A; Wertheimer E; LeRoith D
Endocrinology; 1997 Apr; 138(4):1427-33. PubMed ID: 9075698
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
[TBL] [Abstract][Full Text] [Related]
15. Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria.
Burger AM; Kaur G; Alley MC; Supko JG; Malspeis L; Grever MR; Sausville EA
Cancer Res; 1995 Jul; 55(13):2794-9. PubMed ID: 7796405
[TBL] [Abstract][Full Text] [Related]
16. Effects of protein tyrosine kinase inhibitors on the replication of herpes simplex virus and the phosphorylation of viral proteins.
Yura Y; Kusaka J; Tsujimoto H; Yoshioka Y; Yoshida H; Sato M
Intervirology; 1997; 40(1):7-14. PubMed ID: 9268765
[TBL] [Abstract][Full Text] [Related]
17. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.
Gazit A; Osherov N; Posner I; Yaish P; Poradosu E; Gilon C; Levitzki A
J Med Chem; 1991 Jun; 34(6):1896-907. PubMed ID: 1676428
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation is an obligatory event in IL-2 secretion.
Stanley JB; Gorczynski R; Huang CK; Love J; Mills GB
J Immunol; 1990 Oct; 145(7):2189-98. PubMed ID: 1697878
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
Aflalo E; Iftach S; Segal S; Gazit A; Priel E
Cancer Res; 1994 Oct; 54(19):5138-42. PubMed ID: 7923131
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of tyrosine kinase inhibitors on mineralization of normal and tumor bone cells.
Klein BY; Tepper SH; Gal I; Shlomai Z; Ben-Bassat H
J Cell Biochem; 1997 Jun; 65(3):420-9. PubMed ID: 9138097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
